Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Incivek / Telaprevir – Treatment for Chronic Hepatitis C

In January 2011, it was granted accelerated review by the EMA and received a positive opinion in July 2011. The drug was approved in 2013 and is being marketed under the trade name Incivo in Europe.



Go Top